Education
About Us
Working with TipRanks
Follow Us
Wellnex Life Ltd (DE:22W0)
FRANKFURT:22W0
22W0 Stock Chart & Stats
€0.04
>-€0.01(-1.97%)
At close: 4:00 PM EST
€0.04
>-€0.01(-1.97%)
Day’s Range― - ―
52-Week Range€0.04 - €0.36
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€4.07M
Enterprise Value€15.63M
Total Cash (Recent Filing)€975.00K
Total Debt (Recent Filing)€10.03M
Price to Earnings (P/E)―
Beta1.74
Next Earnings
Aug 28, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding69,955,475
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio0.01
Price to Book (P/B)0.69
Price to Sales (P/S)0.33
P/FCF Ratio-11.64
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Recurring OTC Consumer-health BusinessWellnex operates in the consumer OTC health segment where purchases are recurring and driven by ongoing consumer needs (pain relief, topical care). This business durability supports predictable unit demand and repeat revenue potential, aiding mid-term revenue stability if distribution is maintained.
Established Pharmacy And Retail ChannelsDirect access to pharmacy and retail shelf space is a structural advantage: it improves brand visibility, repeat purchase rates and route-to-market efficiency. Strong channel footholds help sustain sales over months and enable faster roll-out of adjacent products with lower incremental distribution cost.
Positive Gross Profit MarginA positive gross margin shows product-level economics can cover direct costs and suggests scalable unit profitability if overheads are controlled. This provides an operational lever to restore overall profitability over several quarters through tighter SG&A or volume-driven fixed-cost absorption.
Bears Say
Negative Operating And Free Cash FlowPersistent negative operating and free cash flows indicate the business is burning cash to fund operations and growth. Over 2-6 months this constrains investment in marketing, inventory and product development, raises financing needs, and increases dilution or refinancing risk if cash generation doesn't improve.
Sustained Unprofitability (negative Margins)Negative EBIT and net margins show the company is not yet covering operating expenses after COGS. This structural profitability gap limits free cash flow conversion and requires either sustained revenue acceleration or structural cost reduction to reach self-funding and support durable shareholder returns.
Negative Return On EquityA negative ROE demonstrates the business is eroding shareholder capital rather than generating returns. Persisting for multiple quarters, this raises longer-term concerns about capital allocation, potential equity raises, and investor confidence, constraining strategic flexibility and value creation.
Wellnex Life Ltd News
22W0 FAQ
What was Wellnex Life Ltd’s price range in the past 12 months?
Wellnex Life Ltd lowest stock price was €0.04 and its highest was €0.36 in the past 12 months.
What is Wellnex Life Ltd’s market cap?
Wellnex Life Ltd’s market cap is €4.07M.
When is Wellnex Life Ltd’s upcoming earnings report date?
Wellnex Life Ltd’s upcoming earnings report date is Aug 28, 2026 which is in 172 days.
How were Wellnex Life Ltd’s earnings last quarter?
Wellnex Life Ltd released its earnings results on Feb 26, 2026. The company reported -€0.016 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.016.
Is Wellnex Life Ltd overvalued?
According to Wall Street analysts Wellnex Life Ltd’s price is currently Overvalued.
Does Wellnex Life Ltd pay dividends?
Wellnex Life Ltd does not currently pay dividends.
What is Wellnex Life Ltd’s EPS estimate?
Wellnex Life Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Wellnex Life Ltd have?
Wellnex Life Ltd has 69,955,475 shares outstanding.
What happened to Wellnex Life Ltd’s price movement after its last earnings report?
Wellnex Life Ltd reported an EPS of -€0.016 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -3.774%.
Which hedge fund is a major shareholder of Wellnex Life Ltd?
Currently, no hedge funds are holding shares in DE:22W0
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Wellnex Life Ltd Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-75.69%
12-Months-Change
Fundamentals
Return on Equity
-92.72%
Trailing 12-Months
Asset Growth
-17.21%
Trailing 12-Months
Company Description
Wellnex Life Ltd
Wellnex Life Limited develops health and wellness solutions in Australia. The company provides organic baby skincare products under the Little Innoscents; nutritional support products under the Performance Inspired; iron gummies under The Iron Company; organic milk under the Uganic; natural energy products under the Wakey Wakey; smooth textured capsules under the Liquigesic; and garlic products under the SupaGarlic brands. It also offers bin cleanser solutions under the Bin Buddy; medical products under the Bird Healthcare; gel plasters for treating blisters, corns, cracked heels, and cold sores under the Compeed; oral emergency contraception pills under the EllaOne; skincare solutions under the Koéna; canned meats under the Plumrose; snacks under the Simply7; skincare products under the edited; natural herbal skincare products under the naked klay; and natural essential oil blends under the Planet Remedy brands. In addition, the company provides contract manufacturing services. Wellnex Life Limited has a collaboration with Onelife Botanicals for the manufacture, distribution, and sales of cannabis and hemp-based products. The company was formerly known as Wattle Health Australia Limited and changed its name to Wellnex Life Limited in June 2021. Wellnex Life Limited was incorporated in 2011 and is headquartered in Melbourne, Australia.
Technical Analysis
EVE Health Group Limited
―
Nuchev Pty Ltd
―
―
Holista Colltech Limited
―
Nutritional Growth Solutions Ltd.
―
Options Prices
Currently, No data available
---